Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates-Reference-Cited by-同舟云学术

Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates

Published:2019-02 Issue:6 Volume:37 Page:863-868
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Vannice Kirsten S.,Cassetti M. Cristina,Eisinger Robert W.,Hombach Joachim,Knezevic Ivana,Marston Hilary D.,Wilder-Smith Annelies,Cavaleri Marco,Krause Philip R.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference44 articles.

1. World Health Organization. WHO global consultation on research related to Zika virus infection. Available at .

2. Zika vaccines and therapeutics: landscape analysis and challenges ahead;Wilder-Smith;BMC Med,2018

3. World Health Organization. Zika vaccine development technical roadmap; 2018. Available at .

4. VRC 705: a Zika virus DNA vaccine in healthy adults and adolescents. Available at .

5. Safety, tolerability, and immunogenicity of mRNA-1325 in healthy adult subjects. Available at .

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice;Vaccine;2024-11

2. Evaluation of the antiviral activity of new dermaseptin analogs against Zika virus;Biochemistry and Biophysics Reports;2024-09

3. Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection;npj Vaccines;2024-08-28

4. Predicting Efficacy of a Purified Inactivated Zika Virus Vaccine in Flavivirus-Naïve Humans Using an Immunological Correlate of Protection in Non-Human Primates;Microorganisms;2024-06-11

5. Rational design and production of a chimeric antigen targeting Zika virus that induces neutralizing antibodies in mice;Vaccine;2024-06